In the Matter of Staples/Essendant, Inc., File No. 1810180
It is never a good idea to destroy competition. That is how we ended up paying higher prices for necessary life sustaining medications like epi-pens. Competition protects the regular consumer like me who does not receive payments to support big pharm companies-see I only have my retirement.